Jan 19, 2022 by James HalleyWhy Ziopharm Oncology Shares Rose 10.5% on WednesdayThe clinical-stage biotech saw a slight bounce-back from its lows of last week.
Jan 18, 2022 by James HalleyWhy Shares of Dyne Therapeutics Dropped 18.1% on TuesdayA clinical hold regarding one of the company's therapies brought Dyne's shares to a 52-week low.
Jan 12, 2022 by James HalleyWhy Shares of Viatris Fell 27.8% in 2021The company, formed by the merger of Mylan and the Upjohn division of Pfizer, has underwhelmed investors.
Jan 11, 2022 by James HalleyThese 2 Nasdaq Stocks Could Carry Your Portfolio for YearsThese value stocks offer set-it-and-forget-it stability along with above-average dividends.
Jan 10, 2022 by James HalleyWhy Tandem Diabetes Care Stock Rose 17.1% in DecemberFast-improving financials show the medical equipment company has plenty of potential.
Jan 9, 2022 by James HalleyWhy Sherwin-Williams' Shares Soared 43% Higher in 2021The paint-and-coatings giant closed out the year on a strong note.
Jan 4, 2022 by James HalleyWhy Shares of Zomedica Corp. Dropped 22.5% in DecemberThe veterinary diagnostics company has been a volatile stock.
Jan 3, 2022 by James HalleyWhy Shares of ImmunoGen Jumped 20.3% in DecemberThe biotech company that focuses on oncology drugs released news from a positive clinical trial regarding its lead drug.
Jan 3, 2022 by James Halley3 Bargain Medical REITs for Great Dividends in 2022These three medical REITs should benefit from an aging population, all the while rewarding investors with income from dividends.
Dec 29, 2021 by James Halley3 Under-the-Radar Cannabis Stocks for 2022You may not have heard of these three cannabis companies, but you'll like their revenue growth and long-term prospects.
Dec 27, 2021 by James HalleyWhy Co-Diagnostics Stock Rose 15.8% on MondayThe molecular testing company is expected to benefit from the rise in cases of the omicron COVID-19 variant.
Dec 23, 2021 by James HalleyThe Worst Mistake Pfizer Investors Can Make in 2022The company's share price and revenue have soared in 2021, and that's likely only the beginning.
Dec 22, 2021 by James HalleyWhy Acadia Pharmaceuticals Stock Climbed More Than 10% WednesdayThe biotech saw a rebound after a down day on Tuesday.
Dec 20, 2021 by James HalleyWhy BioDelivery Sciences International Stock Was Up 28.5% MondayThe biotech company received a favorable court ruling regarding its lead therapy.
Dec 17, 2021 by James HalleyWhy Hexo Stock Was Down 11.8% This WeekThe Canadian cannabis stock, already below $1 a share, fell even further.
Dec 16, 2021 by James HalleyWhy Arcturus Therapeutics Stock Was Up 16% ThursdayThe biotech stock climbed more than $5 a share in early trading Thursday.
Dec 16, 2021 by James HalleyUnstoppable Dividend King for 2022: AbbVie or Johnson & Johnson?Both of these two healthcare stocks have potential. Which one has a better year ahead?
Dec 15, 2021 by James HalleyWhy Legend Biotech Shares Plummeted 17.6% WednesdayThe clinical-stage biotech company's stock dropped more than $4 a share from its Tuesday close.
Dec 15, 2021 by James Halley3 Incredibly Cheap Dividend Stocks Worth a Closer LookThese dividend stocks are a great place to find high yields in a low-interest economic environment.
Dec 11, 2021 by James Halley2 Hot Stocks to Buy and Hold Until You RetireThese companies have had a strong 2021, with plenty of room to grow.
